Wave Life Sciences Ltd (WVE)

Apr 21, 2025

(WVE) Investment Report - news.stocktradersdaily.com

Apr 21, 2025

Apr 15, 2025

Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely? - Yahoo Finance

Apr 15, 2025

Apr 13, 2025

Wave Life Sciences (NASDAQ:WVE) Earns Outperform Rating from Analysts at Wedbush - MarketBeat

Apr 13, 2025

Apr 11, 2025

Wave Life Sciences (WVE) Price Target Reduced by B. Riley Amid F - GuruFocus

Apr 11, 2025

Apr 10, 2025

B. Riley Adjusts Wave Life Sciences' Price Target to $19 From $22, Keeps Buy Rating - MarketScreener

Apr 10, 2025

Apr 08, 2025

Wedbush sets $18 target for WAVE Life Sciences stock By Investing.com - Investing.com India

Apr 08, 2025

Apr 08, 2025

Wedbush sets $18 target for WAVE Life Sciences stock - Investing.com Australia

Apr 08, 2025

Apr 08, 2025

Wedbush Initiates Wave Life Sciences at Outperform With $18 Price Target - MarketScreener

Apr 08, 2025

Apr 04, 2025

(WVE) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 04, 2025

Apr 04, 2025

Wave Life Sciences Ltd.'s (NASDAQ:WVE) 41% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - simplywall.st

Apr 04, 2025

Apr 03, 2025

RBC Cuts Price Target on Wave Life Sciences to $10 From $14, Keeps Sector Perform, Speculative Risk - MarketScreener

Apr 03, 2025

Mar 31, 2025

Wave Life Sciences’ SWOT analysis: RNA editing pioneer faces challenges in genetic medicine stock - Investing.com India

Mar 31, 2025

Mar 31, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

What is Leerink Partnrs’ Estimate for WVE Q1 Earnings? - Defense World

Mar 31, 2025

Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025

Mar 28, 2025

HC Wainwright Reaffirms “Buy” Rating for Wave Life Sciences (NASDAQ:WVE) - Defense World

Mar 28, 2025

Mar 27, 2025

Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 (NASDAQ:WVE) - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

WAVE Life Sciences stock holds buy rating, $22 target from H.C. Wainwright - Investing.com Australia

Mar 27, 2025

Mar 27, 2025

Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531 - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar? - Nasdaq

Mar 27, 2025

Mar 26, 2025

Wave Life Sciences reports progress in DMD treatment By Investing.com - Investing.com Australia

Mar 26, 2025

Mar 26, 2025

Wave Aspires To Accelerated Approval In DMD With 48-Week Data - insights.citeline.com

Mar 26, 2025

Mar 26, 2025

Riding the Wave, exon skipper sails toward DMD filing - BioWorld Online

Mar 26, 2025

Mar 26, 2025

Sector Update: Health Care Stocks Retreat Wednesday Afternoon - MarketScreener

Mar 26, 2025

Mar 26, 2025

Jefferies maintains Buy on WAVE Life Sciences stock, $26 target By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences to submit Duchenne drug for approval after Phase 2 success - The Boston Globe

Mar 26, 2025

Mar 26, 2025

Jefferies maintains Buy on WAVE Life Sciences stock, $26 target - Investing.com India

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year - Benzinga

Mar 26, 2025

Mar 26, 2025

Wave to seek FDA accelerated approval for Duchenne candidate in 2026 - MSN

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences shares surge on positive DMD trial results By Investing.com - Investing.com Australia

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences shares surge on positive DMD trial results - Investing.com

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences reports progress in DMD treatment - Investing.com India

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences Reports Positive Phase 2 Trial Results - TipRanks

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD - MarketScreener

Mar 26, 2025

Mar 26, 2025

Wave Life Sciences Announces Positive Data from FORWARD-53 - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

Clinical Trial Breakthrough: New DMD Drug Achieves Unprecedented Muscle Recovery - StockTitan

Mar 26, 2025

Mar 24, 2025

Victory Capital Management Inc. Increases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 24, 2025

Mar 23, 2025

Charles Schwab Investment Management Inc. Grows Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 23, 2025

Mar 21, 2025

Wave Life Sciences director Christian Henry sells $102,574 in shares By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Wave Life Sciences director Christian Henry sells $102,574 in shares - Investing.com

Mar 21, 2025

Mar 20, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Bank of New York Mellon Corp - Defense World

Mar 20, 2025

Mar 20, 2025

Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? - Yahoo Finance

Mar 20, 2025

Mar 18, 2025

US Bancorp DE Cuts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 18, 2025

Mar 16, 2025

Arizona State Retirement System Acquires 7,846 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 16, 2025

Mar 15, 2025

How To Trade (WVE) - Stock Traders Daily

Mar 15, 2025

Mar 12, 2025

Wave Life Sciences’ SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com

Mar 12, 2025

Mar 11, 2025

Mizuho maintains WAVE Life Sciences Outperform rating By Investing.com - Investing.com India

Mar 11, 2025

Mar 10, 2025

Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Mar 10, 2025

Mar 09, 2025

Paul Bolno Sells 169,025 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) Stock - Defense World

Mar 09, 2025